Skip to main content

. 1988 Nov 19;297(6659):1316. doi: 10.1136/bmj.297.6659.1316

Is there a genetic factor in flecainide toxicity?

J Beckmann ¹, R Hertrampf ¹, U Gundert-Remy ¹, G Mikus ¹, A S Gross ¹, M Eichelbaum ¹

PMCID: PMC1834956 PMID: 3144374

1316

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Anderson J. L., Stewart J. R., Perry B. A., Van Hamersveld D. D., Johnson T. A., Conard G. J., Chang S. F., Kvam D. C., Pitt B. Oral flecainide acetate for the treatment of ventricular arrhythmias. N Engl J Med. 1981 Aug 27;305(9):473–477. doi: 10.1056/NEJM198108273050901. [DOI] [PubMed] [Google Scholar]
Eichelbaum M. Polymorphic drug oxidation in humans. Fed Proc. 1984 May 15;43(8):2298–2302. [PubMed] [Google Scholar]
Salerno D. M., Granrud G., Sharkey P., Krejci J., Larson T., Erlien D., Berry D., Hodges M. Pharmacodynamics and side effects of flecainide acetate. Clin Pharmacol Ther. 1986 Jul;40(1):101–107. doi: 10.1038/clpt.1986.145. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES